Skip to main content

Thierry André, MD

Thierry Andre, MD, St Antoine Hospital
Videos
02/04/2025
Thierry Andre, MD, describes results from the CheckMate 8HW trial which evaluated nivolumab plus ipilimumab compared with nivolumab monotherapy among patients with MSI-H/dMMR metastatic colorectal cancer.
Thierry Andre, MD, describes results from the CheckMate 8HW trial which evaluated nivolumab plus ipilimumab compared with nivolumab monotherapy among patients with MSI-H/dMMR metastatic colorectal cancer.
Thierry Andre, MD, describes...
02/04/2025
Oncology
Thierry André, MD, Saint-Antoine Hospital
Videos
08/24/2023
At the 2023 World Congress on Gastrointestinal Cancers, Thierry André, MD, discussed the use of checkpoint inhibitors for patients with MSI-high colorectal cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Thierry André, MD, discussed the use of checkpoint inhibitors for patients with MSI-high colorectal cancer.
At the 2023 World Congress on...
08/24/2023
Oncology
Thierry André, MD, Saint Antoine Hospital
Videos
01/23/2024
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the...
01/23/2024
Oncology